FDA approves Foundation Medicine ’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

Roche announced today that the US Food and Drug Administration (FDA) has approved FoundationOne CDx ™, Foundation Medicine’s comprehensive companion diagnostic assay for personalised oncology care.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news